ScopusElsevier Scopus
Status
Inactive/Discontinued
Coverage
2005 (also 2001–2003, 1999, 1996–1997, 1990–1994, 1987–1988)
Source type
Journal
Open access
No
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer chemotherapy and biological response modifiers
Cancer chemotherapy and biological response modifiers is not currently indexed in Scopus. Published by Elsevier B.V..
ISSN 0921-4410Verify ISSN ↗
Publisher: Elsevier B.V.
Scopus · Inactive
0
Indexed in
major indexes
Cost to publish: No APC data — check the publisher
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Not listed in Web of Science.
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Is Cancer chemotherapy and biological response modifiers indexed in Scopus? No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2005 (also 2001–2003, 1999, 1996–1997, 1990–1994, 1987–1988)).
What is the impact factor of Cancer chemotherapy and biological response modifiers? Cancer chemotherapy and biological response modifiers has no Journal Impact Factor — JIF is published only for Web of Science SCIE and SSCI titles — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Is Cancer chemotherapy and biological response modifiers in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Cancer chemotherapy and biological response modifiers open access? No — it is not registered as an open-access journal in DOAJ or Scopus.
Impact & reach — open metrics via OpenAlex
15
h-index
0
2-yr mean citations
22
i10-index
93
works indexed
624
total citations
Cancer chemotherapy and biological response modifiers published 45 papers in 2005; its busiest recent year was 2003 with 48. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-09-24.
Integrity signals — indicators, not proof of misconduct
- Scopus statusInactive — coverage ended 2005
- Retracted papers None recorded
Retractions and authorship from OpenAlex; Scopus status from the Scopus source list. A signal marks something to look at more closely; it is not a finding against the journal.
Official sources & links
Related journals
- Cancer Detection and Prevention
- Capturing Intelligence
- Carbon Trends Scopus Q2 WoS ESCI
- Card Technology Today
- Cardioscience
- Cardiovascular Radiation Medicine
- CASE Scopus Q4
- Case Reports in Women's Health Scopus Q3 WoS ESCI
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.